Company Sino Biopharmaceutical Limited

1177

KYG8167W1380

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:38:03 20/05/2026 pm IST			5-day change	1st Jan Change
5.170 ^HKD	-1.34%		-10.55%	-16.34%

11/05	Global markets live: Alphabet, Cerebras, Compass, GSK, Rockwool…
11/05	Hong Kong Stocks Little Changed as U.S.-Iran Talks Remain Deadlocked; LDROBOT Gains on Debut	MT

Business description: Sino Biopharmaceutical Limited

Sino Biopharmaceutical Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company operates its business through three segments. The Modernised Chinese Medicines and Chemical Medicines segment is mainly engaged in the manufacture, sale and distribution of modernised Chinese medicine products and western medicine products. The Investment segment is mainly engaged in the long term investments business. The Others segment is mainly engaged in the related healthcare and hospital business.

Number of employees: 21,435

Sales by Activity: Sino Biopharmaceutical Limited

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Pharmaceuticals	-	-	-	-	3.18TCr
Modernised Chinese Medicines and Chemical Medicines	2.62TCr	2.82TCr	2.58TCr	2.85TCr	-
Others	63Cr	55Cr	43Cr	40Cr	-

See all business segments

Geographical breakdown of sales: Sino Biopharmaceutical Limited

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Mainland China	2.69TCr	2.88TCr	2.62TCr	2.89TCr	3.18TCr

See all geographic segments

Executive Committee: Sino Biopharmaceutical Limited

Manager	Title	Age	Since
S Y Tse CEO	Chief Executive Officer	30	28/07/2022
Chun Ling Li DFI	Director of Finance/CFO	55	01/01/1996
Hsin Tse IRC	Investor Relations Contact	56	25/04/2013
Kuen Lai SEC	Corporate Secretary	-	13/01/2026
Philip Duong CIO	Chief Investment Officer	36	01/01/2020

See SINO BIOPHARMACEUTICAL LIMITED governance

Composition of the Board of Directors: Sino Biopharmaceutical Limited

Director	Title	Age	Since
Ping Tse CHM	Chairman	74	02/02/2000
Hsin Tse BRD	Director/Board Member	56	01/08/1995
Cheung Ling Cheng BRD	Director/Board Member	62	10/04/2017
Zheng Fei Lu BRD	Director/Board Member	63	23/02/2010
Da Kui Li BRD	Director/Board Member	82	23/02/2010
Zhou Shan Tian BRD	Director/Board Member	62	01/04/1997
Hong Lu BRD	Director/Board Member	56	20/04/2015
Lu Fu Zhang BRD	Director/Board Member	69	20/04/2015
Theresa Y. Y. Tse CHM	Chairman	33	30/06/2015
S Y Tse BRD	Director/Board Member	30	23/10/2019

Composition of the Board of Directors

Shareholders: Sino Biopharmaceutical Limited

Name	Equities	%	Valuation
S Y Tse 21.63 %	4,05,50,00,000	21.63 %	2 806 M $
Cheung Ling Cheng 15.86 %	2,97,36,78,124	15.86 %	2 057 M $
Ping Tse 9.038 %	1,69,42,70,241	9.038 %	1 172 M $
Hsin Tse 1.923 %	36,05,57,270	1.923 %	249 M $
Yinhua Fund Management Co., Ltd. 0.7352 %	13,78,19,000	0.7352 %	95 M $

List of SINO BIOPHARMACEUTICAL LIMITED shareholders

Holdings: Sino Biopharmaceutical Limited

Name	Equities	%	Valuation
HANCHORBIO INC. 1.74%	22,65,786	1.74%	10 M $

Company details: Sino Biopharmaceutical Limited

Sino Biopharmaceutical Ltd.

Office Tower

, Hong Kong

+852 2802 9886

http://www.sinobiopharm.com

address Sino Biopharmaceutical Limited(1177)

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
SINO BIOPHARMACEUTICAL LIMITED	-1.34%	-10.55%	+27.34%	+31.89%	1.19TCr
ELI LILLY AND COMPANY	-0.25%	+2.93%	+34.93%	+130.32%	91TCr
JOHNSON & JOHNSON	-0.30%	+2.26%	+50.38%	+44.31%	55TCr
ABBVIE INC.	-0.68%	+2.14%	+14.32%	+46.30%	38TCr
ROCHE HOLDING AG	-0.42%	+2.05%	+26.19%	+13.82%	33TCr
ASTRAZENECA PLC	+0.50%	+1.47%	+34.50%	+16.15%	29TCr
NOVARTIS AG	-0.42%	+2.28%	+29.48%	+30.97%	29TCr
MERCK & CO., INC.	-1.09%	+0.56%	+46.32%	-2.16%	28TCr
NOVO NORDISK A/S	+0.31%	-2.73%	-34.26%	-49.84%	20TCr
AMGEN INC.	+0.25%	-1.40%	+20.20%	+48.41%	18TCr
Average	-0.34%	+0.32%	+24.94%	+31.02%	34.21TCr
Weighted average by Cap.	-0.29%	+2.11%	+29.96%	+51.86%